NCT01372332View on ClinicalTrials.gov

Assessment of Homonymous Visual Loss and Its Impact on Visual Exploration, Activities of Daily Living (ADL) and Quality of Life (QoL)

CompletedOBSERVATIONAL
Enrollment

60

Participants

Timeline

Start Date

June 30, 2011

Primary Completion Date

April 30, 2013

Study Completion Date

April 30, 2013

Conditions
Homonymous Hemianopia
Trial Locations (1)

D-72076

Centre for Ophthalmology Institute for Ophthalmic Research University of Tübingen, Tübingen

All Listed Sponsors
collaborator

Merck Sharp & Dohme LLC

INDUSTRY

lead

University Hospital Tuebingen

OTHER

NCT01372332 - Assessment of Homonymous Visual Loss and Its Impact on Visual Exploration, Activities of Daily Living (ADL) and Quality of Life (QoL) | Biotech Hunter | Biotech Hunter